Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

PAVmed (PAVM) Other financing activities (2017 - 2021)

PAVmed has reported Other financing activities over the past 1 years, most recently at $1.3 million for Q1 2021.

For Q1 2021, Other financing activities changed N/A year-over-year to $1.3 million; the TTM value through Dec 2021 reached $1.3 million, changed N/A, while the annual FY2021 figure was $1.3 million, N/A changed from the prior year.
Other financing activities for Q1 2021 was $1.3 million at PAVmed.
Over five years, Other financing activities peaked at $1.3 million in Q1 2021 and troughed at $1.3 million in Q1 2021.